nanjing zijinshan artificial intelligence research institute was successfully rated as nanjing engineering research center
2024-09-03
한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina
yangtze evening news reported on september 3 (reporter jin yuxi) recently, the nanjing municipal development and reform commission issued the "notice of the municipal development and reform commission on the approval of the construction of nanjing engineering research center in 2024". after enterprise application, review and recommendation by various sections, formal review, and expert review, the "nanjing "ai+" preclinical drug discovery and design engineering research center" applied by nanjing purple mountain artificial intelligence research institute (referred to as "purple mountain research institute") was successfully selected.
nanjing "ai+" preclinical drug discovery and design engineering research center focuses on the application of ai technology in pharmaceutical research and development in the development of future industries - the third-generation semiconductor industry. it builds innovative platforms such as pharmaceutical research and development collaboration platforms, intelligent clinical trial platforms, co-construction of scientific research data collection systems, one-stop service platforms for drug research and development, and ai+ laboratories. it conducts research on ai-driven drug target discovery, ai drug design and screening, ai-assisted clinical trials and efficacy verification, ai data platforms and model optimization, and breaks through key technologies such as efficient target discovery and verification, intelligent drug molecule design and screening, clinical trial design and data analysis optimization, large-scale biomedical data processing and integration, and ai model training and optimization.
this recognition fully affirms the technological innovation capabilities of zijinshan research institute in the field of drug discovery and design. in the future, the company will continue to enhance its r&d capabilities, promote the close integration of scientific research and production, accelerate the industrialization process of high-tech, and further enhance the company's core competitiveness and brand influence.
proofread by tao shangong
